pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Vaccine · news · pharmadog
← back to Vaccine
News · Vaccine
688
stories
24d
#ESMO26: Merck and Moderna's cancer vaccine data were 'a triumph of science.' And now, the work begins
endpoints
24d
STAT+: After a cancer vaccine’s first success, the race is on to expand the impact
stat
25d
STAT+: The ESMO presentation everyone’s been waiting for
stat
25d
Cancer vaccine data from #ESMO26; Treasury proposal could curb China investment; and more
endpoints
26d
‘It is what it is’: Merck exec unruffled by ‘unfortunate’ leak of ESMO cancer vaccine data
fiercebiotech
26d
STAT+: Highly anticipated Moderna-Merck melanoma cancer vaccine data arrived early
stat
26d
STAT+: Diabetes association says ‘threat’ preceded members’ ejections, but admits policies were unclear
stat
26d
STAT+: Most cancer drugs approved by European regulators lack a high clinical benefit, analysis finds
stat
26d
STAT+: Up and down the ladder: The latest comings and goings
stat
26d
STAT+: Tango builds on Revolution Medicines’ pancreatic cancer success
stat
26d
Anxiety builds over Medicaid work requirements
stat
26d
STAT+: Treasury proposes major restrictions to U.S. investment in Chinese biotech sector
stat
26d
ESMO 2026: Marengo's bispecific antibody shrinks 8 tumor types in Phase 2
biospace
26d
STAT+: Pharmalittle: We’re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more
stat
26d
STAT+: AI drug firm Pathos raises $237 million, pushing valuation to $3 billion
stat
26d
Tango combo clears Rasonque bar, Takeda's Innovent bet gets early returns, plus more from #ESMO26
endpoints
26d
STAT+: Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer
stat
26d
STAT+: Alnylam says Huntington’s drug shows promise in early study
stat
27d
ESMO 2026: Merck, Moderna shares fall as cancer vaccine disappoints after data leak
biospace
27d
Pfizer details mixed Lyme disease vaccine data
endpoints
27d
Moderna, Merck shares fall on eagerly anticipated cancer vaccine results
biopharma dive
27d
STAT+: Detailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial
stat
27d
#ESMO26: Data leak for Merck and Moderna’s therapeutic cancer vaccine
endpoints
27d
STAT+: AbbVie skin disorder drug succeeds in late-stage trial, but results miss market expectations
stat
27d
STAT+: Will the Treasury restrict U.S. investment in the Chinese biotech sector?
stat
27d
STAT+: What to expect from the Moderna-Merck cancer vaccine data reveal
stat
27d
Health insurance premiums jump 9%, and more Americans don’t have access to coverage
stat
28d
Critical decisions that spurred these 40 Under 40 winners to success
biospace
28d
Disc’s redemption, China’s rise, Veradermics’ validation, ESMO’s headliners
biospace
28d
Nigeria identifies travel-related Ebola case
stat
← prev
page 4 of 23
next →